Adjusting Our Approach to Multiparametric Magnetic Resonance Imaging-based Targeted Prostate Biopsies: Considerations After the FUTURE Trial

Affiliations

¹ Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
² Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. Electronic address: rreiter@mednet.ucla.edu.

Editorial

Taylor Y Sadun et al. Eur Urol. 2019 Apr.

. 2019 Apr;75(4):591-592.

doi: 10.1016/j.eururo.2018.12.023. Epub 2018 Dec 24.

¹ Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
² Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. Electronic address: rreiter@mednet.ucla.edu.

No abstract available

Comment on

The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies.
Wegelin O, Exterkate L, van der Leest M, Kummer JA, Vreuls W, de Bruin PC, Bosch JLHR, Barentsz JO, Somford DM, van Melick HHE. Wegelin O, et al. Eur Urol. 2019 Apr;75(4):582-590. doi: 10.1016/j.eururo.2018.11.040. Epub 2018 Dec 3. Eur Urol. 2019. PMID: 30522912 Clinical Trial.